Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Blood ; 109(2): 552-9, 2007 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-16990611

RESUMO

Defective regulation of platelet activation/aggregation is a predominant cause for arterial thrombosis, the major complication of atherosclerosis triggering myocardial infarction and stroke. A central regulatory pathway conveying inhibition of platelet activation/aggregation is nitric oxide (NO)/cyclic GMP (cGMP) signaling by cGMP-dependent protein kinase I (cGKI). However, the regulatory cascade downstream of cGKI mediating platelet inhibition is still unclear. Here, we show that the inositol-1,4,5-trisphosphate receptor-associated cGMP kinase substrate (IRAG) is abundantly expressed in platelets and assembled in a macrocomplex together with cGKIbeta and the inositol-1,4,5-trisphosphate receptor type I (InsP3RI). cGKI phosphorylates IRAG at Ser664 and Ser677 in intact platelets. Targeted deletion of the IRAG-InsP3RI interaction in IRAGDelta12/Delta12 mutant mice leads to a loss of NO/cGMP-dependent inhibition of fibrinogen-receptor activation and platelet aggregation. Intracellular calcium transients were not affected by DEA/NO or cGMP in mutant platelets. Furthermore, intravital microscopy shows that NO fails to prevent arterial thrombosis of the injured carotid artery in IRAGDelta12/Delta12 mutants. These findings reveal that interaction between IRAG and InsP3RI has a central role in NO/cGMP-dependent inhibition of platelet aggregation and in vivo thrombosis.


Assuntos
GMP Cíclico/metabolismo , Proteínas de Membrana/fisiologia , Óxido Nítrico/metabolismo , Fosfoproteínas/fisiologia , Agregação Plaquetária/fisiologia , Transdução de Sinais/fisiologia , Trombose/prevenção & controle , Animais , Cálcio/metabolismo , Proteínas Quinases Dependentes de GMP Cíclico/metabolismo , Ativadores de Enzimas/farmacologia , Humanos , Receptores de Inositol 1,4,5-Trifosfato/metabolismo , Peptídeos e Proteínas de Sinalização Intracelular/metabolismo , Proteínas de Membrana/genética , Camundongos , Camundongos Knockout , Complexos Multiproteicos/metabolismo , Fosfoproteínas/genética , Fosforilação , Agregação Plaquetária/efeitos dos fármacos , Valores de Referência , Transdução de Sinais/efeitos dos fármacos , Trombose/metabolismo
2.
Cell Microbiol ; 5(5): 343-51, 2003 May.
Artigo em Inglês | MEDLINE | ID: mdl-12713492

RESUMO

Burkholderia cepacia H111, which was isolated from a cystic fibrosis patient, effectively kills the nematode Caenorhabditis elegans. Depending on the medium used for growth of the bacterium two different killing modes were observed. On high-osmolarity medium the nematodes became paralysed and died within 24 h. Using filter assays we provide evidence that this killing mode involves the production of an extracellular toxin. On nematode growth medium killing occurs over the course of 2-3 days and involves the accumulation of bacteria in the intestinal lumen of C. elegans. We demonstrate that the cep quorum-sensing system of H111 is required for efficient killing of C. elegans under both killing conditions. Using the C. elegans phm-2 mutant that has a non-functional grinder evidence is provided that the cep system is required to enter the intestinal lumen but is dispensable for the colonization of the gut. Furthermore, we demonstrate that the type II secretion machinery is not essential for nematode killing.


Assuntos
Burkholderia cepacia/patogenicidade , Caenorhabditis elegans/microbiologia , Animais , Proteínas de Bactérias/genética , Proteínas de Bactérias/fisiologia , Burkholderia cepacia/genética , Burkholderia cepacia/fisiologia , Caenorhabditis elegans/genética , Proteínas de Caenorhabditis elegans/genética , Genes Bacterianos , Genes de Helmintos , Intestinos/microbiologia , Mutação , Virulência/genética , Virulência/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...